| 000 | 01748 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517054900.0 | ||
| 264 | 0 | _c20160504 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1471-2334 | ||
| 024 | 7 |
_a10.1186/s12879-015-1138-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorja-Tabora, Charissa Fay Corazon | |
| 245 | 0 | 0 |
_aLong-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. _h[electronic resource] |
| 260 |
_bBMC infectious diseases _cOct 2015 |
||
| 300 |
_a409 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningococcal Infections _xprevention & control |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aSerogroup |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aVaccines, Conjugate _ximmunology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMontalban, Cecilia | |
| 700 | 1 | _aMemish, Ziad A | |
| 700 | 1 | _aBoutriau, Dominique | |
| 700 | 1 | _aKolhe, Devayani | |
| 700 | 1 | _aMiller, Jacqueline M | |
| 700 | 1 | _aVan der Wielen, Marie | |
| 773 | 0 |
_tBMC infectious diseases _gvol. 15 _gp. 409 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12879-015-1138-y _zAvailable from publisher's website |
| 999 |
_c25325881 _d25325881 |
||